Artikel dengan mandat akses publik - Suet Feung ChinPelajari lebih lanjut
Tidak tersedia di mana pun: 6
Tinjau
Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer
B Li, T Ni Chonghaile, Y Fan, SF Madden, R Klinger, AE O'Connor, ...
Cancer research 77 (14), 3834-3845, 2017
Mandat: Science Foundation Ireland, Cancer Research UK, UK Medical Research Council …
Tinjau
Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer
M Frye, I Dragoni, SF Chin, I Spiteri, A Kurowski, E Provenzano, A Green, ...
Cancer letters 289 (1), 71-80, 2010
Mandat: Cancer Research UK
Tinjau
Big data in cancer genomics
AT Maia, SJ Sammut, A Jacinta-Fernandes, SF Chin
Current Opinion in Systems Biology 4, 78-84, 2017
Mandat: Fundação para a Ciência e a Tecnologia, Portugal, Cancer Research UK …
Tinjau
BET inhibition as a rational therapeutic strategy for invasive lobular breast cancer
L Walsh, KE Haley, B Moran, B Mooney, F Tarrant, SF Madden, ...
Clinical Cancer Research 25 (23), 7139-7150, 2019
Mandat: Science Foundation Ireland, Breast Cancer Now, UK, Cancer Research UK …
Tinjau
Profiling Precursor microRNAs of Breast Cancer From Total RNA Sequencing Data to Gain Insights Into Their Roles and Prognostic Values
S Wu, JW Pan, M Citartan, TH Tang, MyBrCa Collaborative Group, ...
Genes, Chromosomes and Cancer 64 (2), e70027, 2025
Mandat: Cancer Research UK, National Institute for Health Research, UK
Tinjau
Cameron C. Young, Katherine Eason, Raquel Manzano Garcia, Richard Moulange 3
S Mukherjee, SF Chin, C Caldas, OM Rueda
Scientific Reports 14, 11861, 2024
Mandat: Cancer Research UK, UK Medical Research Council, National Institute for …
Tersedia di suatu tempat: 91
Tinjau
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ...
Nature 486 (7403), 346-352, 2012
Mandat: US National Institutes of Health, Cancer Research UK
Tinjau
Analysis of circulating tumor DNA to monitor metastatic breast cancer
SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ...
New England Journal of Medicine 368 (13), 1199-1209, 2013
Mandat: National Health and Medical Research Council, Australia, Cancer Research UK
Tinjau
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
Mandat: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Tinjau
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ...
Nature 486 (7403), 395-399, 2012
Mandat: US National Institutes of Health, Cancer Research UK
Tinjau
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ...
Nature 481 (7381), 389-393, 2012
Mandat: Cancer Research UK
Tinjau
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ...
Nature 497 (7447), 108-112, 2013
Mandat: National Health and Medical Research Council, Australia, Cancer Research UK
Tinjau
The landscape of cancer genes and mutational processes in breast cancer
PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...
Nature 486 (7403), 400-404, 2012
Mandat: US National Institutes of Health, Research Foundation (Flanders), National …
Tinjau
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ...
Nature communications 7 (1), 11479, 2016
Mandat: Cancer Research UK, National Institute for Health Research, UK
Tinjau
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
C Blenkiron, LD Goldstein, NP Thorne, I Spiteri, SF Chin, MJ Dunning, ...
Genome biology 8, 1-16, 2007
Mandat: Cancer Research UK
Tinjau
A reference map of the human binary protein interactome
K Luck, DK Kim, L Lambourne, K Spirohn, BE Begg, W Bian, R Brignall, ...
Nature 580 (7803), 402-408, 2020
Mandat: US National Institutes of Health, American Heart Association, National Fund …
Tinjau
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ...
Nature communications 6 (1), 8760, 2015
Mandat: Cancer Research UK, UK Medical Research Council, National Institute for …
Tinjau
The shaping and functional consequences of the microRNA landscape in breast cancer
H Dvinge, A Git, S Gräf, M Salmon-Divon, C Curtis, A Sottoriva, Y Zhao, ...
Nature 497 (7449), 378-382, 2013
Mandat: Cancer Research UK
Tinjau
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling
Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ...
Science translational medicine 4 (157), 157ra143-157ra143, 2012
Mandat: Cancer Research UK
Tinjau
Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary element
SW Cho, J Xu, R Sun, MR Mumbach, AC Carter, YG Chen, KE Yost, J Kim, ...
Cell 173 (6), 1398-1412. e22, 2018
Mandat: US National Institutes of Health, Howard Hughes Medical Institute, Cancer …
Informasi terbitan dan pendanaan ditentukan secara otomatis oleh program komputer